Prognosis in HIV
- various studies have reported the dramatic decreases in mortality among individuals infected with human immunodeficiency virus (HIV) since the widespread introduction of highly active antiretroviral therapy (HAART) in industrialized countries
- industrialized countries, persons infected sexually with HIV now appear to experience mortality rates similar to those of the general population in the first 5 years following infection, though a mortality excess remains as duration of HIV infection lengthens
- individuals exposed to HIV through intravenous drug use had a higher excess risk of death than persons infected sexually with HIV
A review has suggested (2) that people living with HIV can currently expect to live a normal life span if able to achieve durable viral suppression on combination antiretroviral therapy
- however this requires lifelong medication and will still suffer from higher rates of cardiovascular, renal, liver and neurologic disease
Reference:
Related pages
Create an account to add page annotations
Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.